Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone demonstrates the full activity of the refolded and purified tissue-type plasminogen activator variant BM 06.022

[1]  S. Fischer,et al.  Mapping of the catalytic site of CHO‐t‐PA and the t‐PA variant BM 06.022 by synthetic inhibitors and substrates , 1992, Protein science : a publication of the Protein Society.

[2]  R. Rudolph,et al.  Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022. , 1992, Protein engineering.

[3]  R. Rudolph.  RENATURATION OF RECOMBINANT, DISULFIDE-BONDED PROTEINS FROH "INCLUSION BODIES" , 1990 .

[4]  F. Castellino,et al.  Reaction of tissue-type plasminogen activator with 4-methylumbelliferyl-p-guanidinobenzoate hydrochloride. , 1988, Biochemical and biophysical research communications.

[5]  R. Smith,et al.  An active-site titrant for human tissue-type plasminogen activator. , 1986, The Biochemical journal.

[6]  M. Lamb,et al.  The incorporation of a fluorescent probe into the active sites of one- and two-chain tissue-type plasminogen activator. , 1986, Archives of biochemistry and biophysics.

[7]  E. Kruithof,et al.  Human tissue-type plasminogen activator. Production in continuous serum-free cell culture and rapid purification. , 1985, The Biochemical journal.

[8]  P. Seeburg,et al.  Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli , 1983, Nature.

[9]  B. Binder,et al.  Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates. , 1979, The Journal of biological chemistry.

[10]  T. Steitz,et al.  X-ray diffraction studies of enzymes. , 1970, Annual review of biochemistry.

[11]  R. Kitz,et al.  Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. , 1962, The Journal of biological chemistry.